BuzzSparks.org

CoLucid Pharmaceuticals


CoLucid Pharmaceuticals, Inc., a biotechnology company, focuses on therapies for central nervous system disorders. The company develops COL-144, a neurally acting anti-migraine agent, which is designed to treat migraine; and COL-204, a conjugated...

Homepage:
Total money raised: $7.5M

Durham
Durham
USA NC

Phone: 919-806-4304

Updated on Jul 16, 2013
CoLucid Pharmaceuticals at CrunchBase
Artthur M. Pappas CEO and Chairman
Jesse I. Treu Board of Director
Past

August, 2011

CoLucid Pharmaceuticals raised $7.5M in unattributed round from Pappas Ventures, Domain Associates, Care Capital, Pearl Street Venture Funds, and Triathlon Medical Venture Partners

CoLucid Pharmaceuticals Raises $7.5 Million of Planned $9.5 Million    prnewswire.com